We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

News   Feb 12, 2019 | Original story from the Society of Nuclear Medicine and Molecular Imaging

 
Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

Representative coronal 18F-FFNP PET/CT images of MDA-MB-231 (red arrow), 231 PR-A (white arrows), and 231 PR-B (yellow arrow) tumor xenografts (19 d after implantation) from 12 mice imaged 1 h after injection with 10 MBq (270 μCi) of 18F-FFNP. Physiologic uptake from hepatobiliary clearance is also visualized. Credit: K Salem et al., University of Wisconsin School of Medicine and Public Health, Madison, WI

 
 
 

RELATED ARTICLES

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

Platform Developed To Help Find Treatments for Mental Health Illnesses

News

Scientists have created a drug discovery platform focused on finding new medication options for people dealing with mental illnesses.

READ MORE

New Drug Combo Could Work Against Broader Array of Cancer Cells

News

Researchers have discovered two drugs that work together to disrupt cancer cells’ ability to survive.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE